MATRIX DECISION PROBABILITY ANALYSIS FOR DEA RESCHEDULING CBD/EPIDIOLEX CBD Schedule I (12%) Schedule II (33%) Schedule III (45%) Schedule IV (7%) Schedule V (3%) EPIDIOLEX Schedule II (5%) Schedule III (8%) Schedule IV (65%) Schedule V (22%) FINAL MATRIX DECISION ANALYSIS PREDICTION CBD — Schedule III Epidiolex — Schedule IV Sleek